IRIS PubliCatt

Sette, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.293
EU - Europa 791
AS - Asia 316
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.402
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.290
PL - Polonia 423
CN - Cina 141
SE - Svezia 129
SG - Singapore 76
IE - Irlanda 47
IT - Italia 45
DE - Germania 42
VN - Vietnam 31
ID - Indonesia 26
AT - Austria 25
GB - Regno Unito 22
RU - Federazione Russa 22
FR - Francia 16
TR - Turchia 16
IN - India 11
HK - Hong Kong 9
UA - Ucraina 9
FI - Finlandia 5
IR - Iran 5
BE - Belgio 2
EU - Europa 2
NO - Norvegia 2
PA - Panama 2
CA - Canada 1
CY - Cipro 1
GR - Grecia 1
RO - Romania 1
Totale 2.402
Salva come PNG Salva come JPEG
Città #
Warsaw 420
Fairfield 205
Chandler 134
Seattle 105
Woodbridge 97
Houston 94
Wilmington 90
Ashburn 89
Cambridge 68
Singapore 60
Dublin 47
Nanjing 42
Redmond 41
Dearborn 32
Dong Ket 31
Jacksonville 27
Bremen 26
Jakarta 26
Princeton 26
Vienna 25
San Mateo 20
Boston 19
Ann Arbor 18
Nanchang 18
Rome 18
Izmir 16
San Diego 15
Moscow 13
Guangzhou 11
Hong Kong 9
Redwood City 9
Andover 8
London 8
Augusta 7
Shenyang 7
Hangzhou 6
Norwalk 6
Chiswick 5
Hebei 5
Helsinki 5
Kish 5
Phoenix 5
Tianjin 5
Cattolica 4
Falls Church 4
Jiaxing 4
Mountain View 4
Acton 3
Beijing 3
Lanzhou 3
Marseille 3
Radoslaw 3
Brussels 2
Chicago 2
Edinburgh 2
Fremont 2
Genova 2
Gualdo Cattaneo 2
Jinan 2
Kunming 2
Los Angeles 2
Milan 2
New York 2
Paris 2
Turin 2
Wuhan 2
Athens 1
Atlanta 1
Bergamo 1
Boardman 1
Bucharest 1
Caserta 1
Changsha 1
Colleferro 1
Frankfurt am Main 1
Fuzhou 1
Genoa 1
Huddinge 1
Islington 1
Marcianise 1
Miami 1
Nagold 1
Nicosia 1
Ningbo 1
Oslo 1
Ottawa 1
Padova 1
Panama City 1
Price 1
Ruvo Di Puglia 1
Sandston 1
Santa Clara 1
Shanghai 1
Shenzhen 1
Washington 1
Totale 2.011
Salva come PNG Salva come JPEG
Nome #
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 278
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 256
The kinase inhibitor SI113 induces autophagy and synergizes with quinacrine in hindering the growth of human glioblastoma multiforme cells 256
Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer 255
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells. 247
PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer 234
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 77
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 72
EGFR Inhibition Abrogates Leiomyosarcoma Cell Chemoresistance through Inactivation of Survival Pathways and Impairment of CSC Potential 64
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts 57
Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma 56
Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models 53
Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells 48
THERAPEUTIC TARGETING OF RAF-INDUCED PARADOXICAL ERK ACTIVATION WITH A VERTICAL COMBINATION HITTING MULTIPLE STEPS ALONG THE MAPK CASCADE 48
Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer 47
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts 45
Aloe-emodin exerts a potent anticancer and immunomodulatory activity on BRAF-mutated human melanoma cells 44
SYNERGISTIC GROWTH INHIBITORY ACTIVITY OF COMBINED MEK/MTOR PATHWAY BLOCKADE IN PTEN-NULL CANCERS 44
Identification and expansion of the tumorigenic lung cancer stem cell population 40
Theratyping cystic fibrosis in vitro in ALI culture and organoid models generated from patient-derived nasal epithelial conditionally reprogrammed stem cells 40
Chemotherapy resistance of glioblastoma stem cells [2] 38
A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells 33
A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors 32
The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms 30
Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction 28
CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells 23
Totale 2.445
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.687
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.687
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020428 0 0 0 0 40 53 87 83 55 20 67 23
2020/2021309 26 29 33 13 47 18 46 5 22 16 20 34
2021/2022233 36 29 4 10 12 14 8 44 11 11 33 21
2022/2023387 46 59 34 57 23 56 6 29 58 4 10 5
2023/2024170 8 69 4 6 2 9 9 1 3 1 37 21
2024/2025105 19 2 27 31 26 0 0 0 0 0 0 0
Totale 2.445